The International Helmholtz Research School for Diabetes is at the core of cutting-edge scientific research at the Helmholtz Diabetes Center in Munich and its partner institution, the Alberta Diabetes Institute in Canada. It offers research projects that enable the development of innovative strategies for the identification of molecular mechanisms, generation of prediction tools, and advancement of therapeutic strategies for type 1 and type 2 diabetes.
The diversity of (epi-)genetic and environmental factors underlying diabetes, as well as the secondary complications resulting from this systemic disease, require highly skilled researchers who will translate fundamental research into clinical solutions for patients. It invites young scientists holding a Master’s degree and a strong interest in diabetes, endocrinology, molecular biology, immunology, public health studies, life sciences, computational biology, clinical research, and related areas to apply to the International Helmholtz Research School for Diabetes.